{"id":"NCT02566993","sponsor":"PharmaMar","briefTitle":"Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer","officialTitle":"Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-08-30","primaryCompletion":"2020-02-24","completion":"2020-02-24","firstPosted":"2015-10-02","resultsPosted":"2021-10-28","lastUpdate":"2021-10-28"},"enrollment":613,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Small-cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Lurbinectedin (PM01183)","otherNames":[]},{"type":"DRUG","name":"Doxorubicin (DOX)","otherNames":[]},{"type":"DRUG","name":"Cyclophosphamide (CTX)","otherNames":[]},{"type":"DRUG","name":"Vincristine (VCR)","otherNames":[]},{"type":"DRUG","name":"Topotecan","otherNames":[]}],"arms":[{"label":"Experimental Arm","type":"EXPERIMENTAL"},{"label":"Control Arm 1","type":"ACTIVE_COMPARATOR"},{"label":"Control Arm 2","type":"ACTIVE_COMPARATOR"}],"summary":"Phase III randomized clinical trial of lurbinectedin (PM01183)/doxorubicin (DOX) versus cyclophosphamide (CTX), doxorubicin (DOX) and vincristine (VCR) (CAV) or topotecan as treatment in patients with small-cell lung cancer (SCLC) who failed one prior platinum-containing line.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"Every three months up to death or study termination, a period of approximately 3.5 years","effectByArm":[{"arm":"Lurbinectedin/Doxorubicin","deltaMin":8.6,"sd":null},{"arm":"Topotecan or Cyclophosphamide/Doxorubicin/Vincristine","deltaMin":7.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.9029"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":160,"countries":["United States","Argentina","Austria","Belgium","Brazil","Bulgaria","Canada","Czechia","France","Germany","Greece","Hungary","Italy","Lebanon","Netherlands","Poland","Portugal","Romania","Spain","United Kingdom"]},"refs":{"pmids":["36252599"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":126,"n":303},"commonTop":["Fatigue","Anaemia","Neutropenia","Nausea","Thrombocytopenia"]}}